P. Hiemstra (Leiden, Netherlands), M. Gjomarkaj (Palermo, Italy)
Protein tyrosine phosphatase PTPRR regulates PP2A in mononuclear cells
Y. Kobayashi, A. Miller-Larsson, K. Ito, A. Kanda, K. Tomoda, P. J. Barnes, N. Mercado (London, United Kingdom; Mölndal, Sweden; Osaka, Japan)
|   |
Particulate matter induces the expression of procoagulant microparticles by human monocytic cells
T. Neri, F. Rota, S. Petrini, Y. Carmazzi, C. Balia, V. Scalise, R. Pedrinelli, V. Bollati, A. Celi (Pisa, Milano, Italy)
| |
Biomass smoke particles induce cytokines and reduce phagocytosis by monocyte-derived macrophages
R. Holloway, T. Guney, B. Brashier, S. Salvi, S. Juvekar, P. Barnes, L. Donnelly (London, United Kingdom; Pune, India)
| |
Differential sensitivity of subsets of monocyte-derived macrophages to apoptosis; its impact on lung inflammation
N. Kurian, D. Cunoosamy (Mölndal, Sweden)
| |
IL-33 and TSLP gene expression are increased in response to human rhinovirus 1B in HDM-treated murine bone marrow-derived macrophages
H. Akbarshahi, M. Menzel, L. Uller (Lund, Sweden)
| |
Phenotypes of alveolar macrophages in normal human lung and their polarization with disease
E. Bazzan, M. Tinè, C. Radu, G. Turato, E. Mutti, P. Simioni, R. Cazzuffi, S. Baraldo, M. Saetta, M. G. Cosio (Padova, Italy; Montreal, Canada)
| |
LSC 2014 abstract - Alternative macrophage polarization and role during lung epithelium injury and repair in vivo
R. Dagher, M. Maret, S. Kozelko, F. Hamidi, G. Gautier, R. Kolbeck, A. Humbles, M. Pretolani (Paris, France; , United States Of America)
| |
Zinc and zinc transporters in human alveolar and THP-1 macrophages and roles in phagocytosis/efferocytosis
P. Zalewski, R. Hamon, H. Tran, H. Jersmann, S. Hodge, M. Bosco (Woodville, Adelaide, Australia)
| |
Disturbed pulmonary immunity and the phenotype of alveolar macrophages in bronchial asthma, gastroesophageal reflux disease and their combination
I. Malyshev, S. Lyamina, I. Maev, G. Yurenev (Moscow, Russian Federation)
| |
Functional phenotype of immune response and alveolar macrophages phenotype in pulmonary sarcoidosis
S. Lyamina, N. Demyanenko, S. Shelukhina, O. Lovacheva, E. Shmelev, I. Malyshev (Moscow, Russian Federation)
| |
The effect of budesonide on TLR expression in alveolar macrophages from smokers
J. Ji, I. von Schéele, B. Billing, B. Dahlén, A. S. Lantz, K. Larsson, L. Palmberg (Stockholm, Sweden)
| |
Hyperoxia impairs the inflammatory response of alveolar macrophages to multiple Toll-like receptor ligands associated with bacterial infection
H. Yamasawa, N. Mato, M. Bando, Y. Sugiyama (Shimotsuke, Japan)
| |
Oxidative stress drives defective efferocytosis in COPD M2-like macrophages
K. Belchamber, R. Singh, J. Wedzicha, M. Whyte, P. Barnes, L. Donnelly (London, Sheffield, United Kingdom)
| |
Nrf2-dependent and -independent cytoprotective actions of the electrophilic Cox-2-derived 17-oxo-DHA in human macrophages
C. Cipollina, S. Di Vincenzo, S. Gerbino, L. Siena, M. Gjomarkaj, E. Pace (Palermo, Italy)
| |
M2 macrophage marker CD163, CD204 and CD206 expression on alveolar macrophages in the lung of patients with chronic obstructive pulmonary
Y. Kaku, H. Imaoka, Y. Morimatu, M. Matsuoka, H. Natori, M. Suetomo, T. Kawayama, T. Hoshino (Kurume, Japan)
| |
Elevated GM-CSF in COPD may drive defective macrophage phenotype
A. Day, P. Barnes, L. Donnelly (London, United Kingdom)
| |
Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD
S. Lyamina, I. Malyshev (Moscow, Russian Federation)
| |
Macrophage migration inhibitory factor (MIF), a biomarker in COPD?
G. Husebø, P. Bakke, J. Hardie, T. Ueland, R. Grønseth, P. Aukrust, T. Eagan (Bergen, Oslo, Norway)
| |